Skip to content
Search

Latest Stories

‘Harmful’ chewed tobacco products face clampdown

Cancer-causing chewed tobacco products are facing a clampdown 16 years after scientists warned of their dangerous contents, a government statement said.

The department of health and social care (DHSC) has told parliament that it plans to regulate ‘most harmful tobacco products’ used by half a million British south Asians who consume betel quid, paan or gutkha -- a mixture of ingredients, including betel nut, herbs, spices and often tobacco, usually wrapped in a betel leaf.


Research has shown that using smokeless tobacco raises the risk of mouth cancer and oesophageal (food pipe) cancer.

Studies have also found that betel itself can raise the risk of cancer, so chewing betel quid without tobacco, which is popular among south Asian women, is still harmful.

In 2006, government chemists found that many of these products contained high levels of carcinogens.

In a paper which analysed the results professors Ann McNeill and Robert West said chewed tobacco was “a major cause of oral cancer” and urged the government to set product standards. However, the government has resisted that and other calls to create standards.

In a recent statement, the government’s former drugs tsar, Professor David Nutt, accused DHSC of “reverse racism” over “lethal” south Asian chewed tobacco.

Professor Nutt has now written about the problem to Javed Khan who has been commissioned by DHSC to write a report on the health disparities caused by tobacco which will be published on 22 April.

The statement further said that the report will influence the department’s forthcoming Tobacco Control Plan, which is due to be published later this year.

According to the Office for National Statistics, smoking rates across the country have been falling steadily over the past 20 years and cigarette use dropped from 15.8 per cent in 2019 to 14.5 per cent in 2020.

However, there are still six million smokers in England. Tobacco remains the single largest cause of preventable death and 64,000 people died from conditions related to smoking in 2019.

NHS community pharmacies are a great place for patients to receive stop smoking advice and support as well as any lifestyle advice.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less